10-88274691-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018363.4(RNLS):c.*270G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0108 in 357,106 control chromosomes in the GnomAD database, including 145 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.021 ( 131 hom., cov: 33)
Exomes 𝑓: 0.0029 ( 14 hom. )
Consequence
RNLS
NM_018363.4 3_prime_UTR
NM_018363.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.631
Genes affected
RNLS (HGNC:25641): (renalase, FAD dependent amine oxidase) Enables several functions, including NADH binding activity; epinephrine binding activity; and monoamine oxidase activity. Involved in negative regulation of blood pressure and negative regulation of heart rate. Located in extracellular region. Implicated in essential hypertension and hypertension. Biomarker of end stage renal disease. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-88274691-C-T is Benign according to our data. Variant chr10-88274691-C-T is described in ClinVar as [Benign]. Clinvar id is 1228173.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0726 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNLS | NM_018363.4 | c.*270G>A | 3_prime_UTR_variant | 7/7 | NP_060833.1 | |||
RNLS | XM_011539924.4 | c.*28+242G>A | intron_variant | XP_011538226.1 | ||||
RNLS | XM_017016380.3 | c.*28+242G>A | intron_variant | XP_016871869.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNLS | ENST00000371947 | c.*270G>A | 3_prime_UTR_variant | 7/7 | 2 | ENSP00000361015.3 |
Frequencies
GnomAD3 genomes AF: 0.0213 AC: 3248AN: 152156Hom.: 131 Cov.: 33
GnomAD3 genomes
AF:
AC:
3248
AN:
152156
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00290 AC: 594AN: 204832Hom.: 14 Cov.: 0 AF XY: 0.00255 AC XY: 277AN XY: 108452
GnomAD4 exome
AF:
AC:
594
AN:
204832
Hom.:
Cov.:
0
AF XY:
AC XY:
277
AN XY:
108452
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0214 AC: 3259AN: 152274Hom.: 131 Cov.: 33 AF XY: 0.0209 AC XY: 1554AN XY: 74468
GnomAD4 genome
AF:
AC:
3259
AN:
152274
Hom.:
Cov.:
33
AF XY:
AC XY:
1554
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 14, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at